epipen

Shareholders Reject EpiPen Maker's $98 Million Payout

Shareholders Reject EpiPen Maker's $98 Million Payout

Mylan Inc. (NASDAQ: MYL) made waves earlier this year by awarding former CEO Robert Coury $98 million despite criticism for increasing the company’s EpiPen by 400 percent over seven years. According to CNNMoney, shareholders of the corpor..

FDA Approves Adamis Pharmaceuticals' EpiPen Competitor

FDA Approves Adamis Pharmaceuticals' EpiPen Competitor

Adamis Pharmaceuticals Corp. (NASDAQ: ADMP) shares jumped more than 60% on Thursday, after the U.S Food and Drug Administration (FDA) approved the Adamis’ Epinephrine injection, a generic version of a Mylan N.V.’s EpiPen, which is a..